In this recap of the connective tissue disease session at Masterclasses APP+, Dr. Merola provides insight on how dermatologists can serve as the front-line provider for treating systemic lupus through the screening, diagnosis, and treatment of cutaneous lupus.
Monica discusses the future of APPs in the rheumatology space and how these clinicians may fill a shortage of rheumatologists in rural areas in the
Dr. Joseph Merola discusses lessons from the Masterclasses meeting that can help both dermatologists and rheumatologists improve their treatment of patients with overlapping conditions. Topics
Dr. Gottlieb provides a robust rundown of new data on an array of biologics for the treatment of psoriasis.
Dr. Alice Gottlieb discusses the latest advancements in biologic and small molecule therapies for hidradenitis suppurativa (HS), highlighting emerging treatments that are transforming patient care.
Dr. Gottlieb discusses a system implemented at Mount Sinai to help dermatologists quickly and easily evaluate and diagnose patients with psoriasis for psoriatic arthritis, then
Rosemary reviews diet choices and supplement considerations for patients with psoriasis and psoriatic arthritis.
Rosemary provides a glimpse at her challenging cases session at the Masterclasses meeting, including lichen planus and cutaneous leishmaniasis in patients with skin of color.
Dr. Rosmarin reviews his process for evaluating itch in a patient and matching patients with different types of itch to the most effective treatment.
Dr. David Rosmarin shares expert hygiene strategies and treatment tips for managing atopic dermatitis, presented at the 2024 Masterclasses in Dermatology. Topics Covered: Patient hygiene
Dr. Han discusses the importance of special-site trials when evaluating treatments for psoriasis in areas such as a scalp and palmoplantar area.
Dr. George Han provides an overview of emerging topical treatments for psoriasis and discusses the findings of the LITE study, which compared the efficacy of
Dr. Basu, a Texas-based rheumatologist, reviews data on a newly approved agent for PSA, nr‐axSpa, and AS.
Dr. Green reviews the most important information for rheumatologists to know about topical treatments for psoriasis.
Dr. Green reviews important lab monitoring guidance and other safety considerations for patients being treated with systemic therapies, mainly for psoriasis.
Dr. Merola, Co-Director of Masterclasses in Dermatology, discusses what makes the interdisciplinary Masterclasses APP+ meeting unique.
Dr. Gottlieb, Co-Director of Masterclasses in Dermatology, provides an overview of stopping and preventing flares in patients with GPP.
Dr. Gottlieb reviews the domains defined by the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) that encompass psoriatic disease.
